Paladin Partners »

Nervgen Pharma Ord shares owned by Paladin Partners

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGENF) shares owned by Paladin Partners from 13F filings

Historical chart of Paladin Partners investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Paladin Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Paladin Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $38k 10k 3.77
2025-12-31 $56k 10k 5.60

More positions owned by Paladin Partners

Ishares Russell 1000 Etf (IWB)
State Street Spdr S&p 500 Etf (SPY)
NVIDIA Corporation (NVDA)
Ishares Russell 1000 Value Etf (IWD)
Vanguard Total Stock Market Etf (VTI)
State Street Spdr Bloomberg Convertible Securities Etf (CWB)
Vanguard Total International Bond Etf (BNDX)
Ishares Iboxx $ High Yield Corporate Bond Etf (HYG)
Ishares Msci Eafe Etf (EFA)
Ishares Core U.s. Aggregate Bond Etf (AGG)
Apple (AAPL)
Ishares Trust Ishares 0-1 Year Treasury Bond Etf (SHV)
Berkshire Hathaway Del Cl B New (BRK.B)
State Street Energy Select Sector Spdr Etf (XLE)
Ishares Russell Midcap Etf (IWR)

View all positions for Paladin Partners

Top funds holding Nervgen Pharma Ord

PFG Investments
Bank of America Corporation
Marshall Wace
Royal Bank of Canada
Integrated Wealth Concepts
Valley Forge Investment Consultants Inc Adv
Bank Of Montreal
Captrust Financial Advisors
UBS Group
Patriot Financial Group Insurance Agency
Commonwealth Equity Services
Cetera Investment Advisers
McKinley Carter Wealth Services
Busey Trust Company
Sprott

View all funds holding Nervgen Pharma Ord